​

VistaGen Therapeutics Ownership | Who Owns VistaGen Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

VistaGen Therapeutics Ownership Summary

VistaGen Therapeutics is owned by 51.91% institutional investors, 0.26% insiders, and 47.83% retail investors. Bfsg is the largest institutional shareholder, holding 0% of VTGN shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 4.43% of its assets in VistaGen Therapeutics shares.

VTGN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVistaGen Therapeutics51.91%0.26%47.83%
SectorHealthcare Stocks 79.82%9.81%10.37%
IndustryBiotech Stocks 63.50%9.87%26.63%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bfsg---
Tower research capital llc (trc)---
Millennium management---
Landscape capital management---
Man group---
Squarepoint ops---
Caption management---
Tcg crossover management---
Goldman sachs group---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bfsg---
Tower research capital llc (trc)---
Millennium management---
Landscape capital management---
Man group---
Squarepoint ops---
Caption management---
Tcg crossover management---
Goldman sachs group---

Top Buyers

HolderShares% AssetsChange
Tower research capital llc (trc)---223.00
Bfsg---1.00K
Caption management---4.46K
Man group---18.34K
Millennium management---38.73K

Top Sellers

HolderShares% AssetsChange
Tcg crossover management---2.68M
Goldman sachs group---194.53K
Squarepoint ops---107.74K
Landscape capital management---41.80K
Millennium management---38.73K

Sold Out

HolderChange
Tower research capital llc (trc)-223.00
Bfsg-1.00K
Caption management-4.46K
Man group-18.34K
Millennium management-38.73K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202551-16.39%15,943,0802.72%512.03%15-54.55%2066.67%
Dec 31, 20246115.09%15,520,6051.70%502.04%3394.12%12-7.69%
Sep 30, 20245312.77%15,260,546-6.59%491.75%1713.33%13-
Jun 30, 20241-2,676,580-1316.67%----
Mar 31, 20241-2,676,580-910.98%--100.00%--

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.28M4.43%-
Vanguard Total Stock Mkt Idx Inv1.19M4.12%-
Vanguard Institutional Extnd Mkt Idx Tr746.07K2.58%-
AdvisorShares Psychedelics ETF180.11K0.62%-
Fidelity Extended Market Index131.88K0.46%7.33K
BlackRock Extended Equity Market K61.89K0.23%-26.00
iShares Micro-Cap ETF62.81K0.22%-
A4Investments SICAV SIF ACCI IlanaA2EURH60.00K0.22%-
Extended Equity Market Fund K61.23K0.21%188.00
Fidelity Total Market Index47.48K0.16%-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 07, 2023COMMODORE CAPITAL LP-Buy$17.96M
Aug 18, 2022GIN JERRY B Buy$17.87K
Aug 17, 2022Adler Reid G. CHIEF LEGAL OFFICERBuy$50.91K
Aug 17, 2022Singh Shawn CHIEF EXECUTIVE OFFICERBuy$103.20K
Jul 12, 2022Shah Nimish P Sell$53.40K

Insider Transactions Trends

DateBuySell
2024 Q1--
2023 Q4--
2023 Q31-
2023 Q2--
2022 Q4--

VTGN Ownership FAQ

Who Owns VistaGen Therapeutics?

VistaGen Therapeutics shareholders are primarily institutional investors at 51.91%, followed by 0.26% insiders and 47.83% retail investors. The average institutional ownership in VistaGen Therapeutics's industry, Biotech Stocks , is 63.50%, which VistaGen Therapeutics falls below.

Who owns the most shares of VistaGen Therapeutics?

VistaGen Therapeutics’s largest shareholders are Bfsg (0 shares, 0%), Tower research capital llc (trc) (0 shares, 0%), and Millennium management (0 shares, 0%). Together, they hold 0% of VistaGen Therapeutics’s total shares outstanding.

Does Blackrock own VistaGen Therapeutics?

BlackRock is not among the top 10 institutional shareholders of VistaGen Therapeutics.

Who is VistaGen Therapeutics’s biggest shareholder by percentage of total assets invested?

Bfsg is VistaGen Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 VistaGen Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of VistaGen Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of VistaGen Therapeutics shares, with 4.43% of its total shares outstanding invested in 1.28M VistaGen Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools